Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document
Héctor M. García‐García(MedStar Washington Hospital Center), Patrick W. Serruys(Ollscoil na Gaillimhe – University of Galway), A. Pieter Kappetein(Erasmus MC), Andrew Farb(Memorial Hermann), Yoshinobu Onuma(Erasmus MC), David P. Taggart(John Radcliffe Hospital), Gregg W. Stone(Cardiovascular Research Foundation), Stephan Windecker, Donald E. Cutlip(Beth Israel Deaconess Medical Center), Pascal Vranckx(Jessa Hospital), William F. Fearon(Stanford Medicine), Eugène McFadden(Skadden Arps Slate Meagher & Flom), Gerrit‐Anne van Es(Centre Hospitalier Universitaire de Caen Normandie), Marie‐Angèle Morel(Ollscoil na Gaillimhe – University of Galway), Bram Zuckerman(United States Food and Drug Administration), John A. Spertus(Spertus Institute for Jewish Learning and Leadership), Mitchell W. Krucoff(Duke University), Roxana Mehran(Icahn School of Medicine at Mount Sinai)
Cited by 926
Related Papers
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
|European Heart Journal|2015|8.3k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease
|New England Journal of Medicine|1994|4.5k
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
|New England Journal of Medicine|2002|4k